Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Diamondcutter who wrote (6392)	4/12/1999 4:33:00 PM
From: Linda Kaplan	Respond to of 7041

Since you purported to be posting an edited version of the report, I thought I should mention that you only posted the positives and omitted the rest (which I'd already posted). As for the safety profile of Vasomax, you realize that many here have disputed the claim that it is safer than Viagra. I sounds like you want to make it a non-issue. But the fact is that it's a serious issue. Additional studies appear to have been required! And we really don't know how they turned out; we only know how Zonagen told Oppenheimer they turned out. My points about that were that ZONA should not be telling Oppenheimer anything, AND, I don't believe that ZONA would give Oppenheimer a report that includes any negatives that appeared. By the way, ZONA closed at 16-5/8. Not at the low, but it rebounded from the day's low all the way up way over 17, so it seems to have been travelling down again before the close. I consider that a good sign for the shorts, that it will continue down tomorrow. Linda